These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30922331)

  • 1. High olive oil diets enhance cervical tumour growth in mice: transcriptome analysis for potential candidate genes and pathways.
    Zhang X; Yang P; Luo X; Su C; Chen Y; Zhao L; Wei L; Zeng H; Varghese Z; Moorhead JF; Ruan XZ; Chen Y
    Lipids Health Dis; 2019 Mar; 18(1):76. PubMed ID: 30922331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis.
    Wu X; Peng L; Zhang Y; Chen S; Lei Q; Li G; Zhang C
    Int J Med Sci; 2019; 16(6):800-812. PubMed ID: 31337953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis.
    Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
    Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome analysis of potential candidate genes and molecular pathways in colitis-associated colorectal cancer of Mkp-1-deficient mice.
    Hammad A; Zheng ZH; Namani A; Elshaer M; Wang XJ; Tang X
    BMC Cancer; 2021 May; 21(1):607. PubMed ID: 34034704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of 10 differentially expressed genes involved in the tumorigenesis of cervical cancer
    Xu J; Yang W; Xie X; Gu C; Zhao L; Liu F; Zhang N; Bai Y; Liu D; Liu H; Jin X; Meng Y
    PeerJ; 2024; 12():e18157. PubMed ID: 39372720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of BRCA1 on the Concurrent Chemoradiotherapy Resistance of Cervical Squamous Cell Carcinoma Based on Transcriptome Sequencing Analysis.
    Wen X; Liu S; Cui M
    Biomed Res Int; 2020; 2020():3598417. PubMed ID: 32685473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src/ERK pathway.
    Yang P; Su C; Luo X; Zeng H; Zhao L; Wei L; Zhang X; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    Cancer Lett; 2018 Dec; 438():76-85. PubMed ID: 30213558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.
    Guo J; Gu Y; Ma X; Zhang L; Li H; Yan Z; Han Y; Xie L; Guo X
    J Cell Mol Med; 2020 Apr; 24(8):4428-4438. PubMed ID: 32147961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics and cheminformatics approaches to identify pathways, molecular mechanisms and drug substances related to genetic basis of cervical cancer.
    Andalib KMS; Rahman MH; Habib A
    J Biomol Struct Dyn; 2023; 41(23):14232-14247. PubMed ID: 36852684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer.
    Bao Y; Wang L; Shi L; Yun F; Liu X; Chen Y; Chen C; Ren Y; Jia Y
    Cell Mol Biol Lett; 2019; 24():38. PubMed ID: 31182966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.
    Zhao J; He K; Du H; Wei G; Wen Y; Wang J; Zhou X; Wang J
    PeerJ; 2022; 10():e13932. PubMed ID: 36157062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
    Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
    Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome profile and its partly verification of human hepatocellular carcinoma cells exposed to Yuzhizi () seed extract.
    Xiaoyan F; Mingzhe LI; Long C; Chao L; Wenli LU; Zhiqiang P; Dongwei J; Peike P; Zhaoqin F; Xiaomei L
    J Tradit Chin Med; 2022 Dec; 42(6):922-931. PubMed ID: 36378050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.